Vas should resign

Discussion in 'Novartis' started by anonymous, Aug 6, 2019 at 4:07 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    it’s also time someone investigated the shady alliance deals in Asia with the likes of Mundipharma and other local companies, who are selling old Novartis products unethically. It will probably happen after existing managers take their bonuses and move to cushy jobs. For all of Vas’ lofty talks, it’s clear that he’s just another bullshitter.
     

  2. anonymous

    anonymous Guest


    Could not agree more !
     
  3. anonymous

    anonymous Guest

    Amen
     
  4. anonymous

    anonymous Guest


    insider tells another insider: Shhhh!


    Novartis Insider Sold Shares in Weeks Before Zolgensma Scandal
    By
    Patrick Winters
    August 18, 2019, 12:59 PM GMT+2


    A Novartis AG manager sold 925,400 francs ($946,000) of shares weeks before a scandal over data for its Zolgensma gene therapy became public.

    The sale on July 19 was made by an executive member of the board of directors or a member of the executive committee, according to a Swiss stock exchange filing.

    That was after Novartis had informed the U.S. Food and Drug Administration about problematic data for Zolgensma, but before the public became aware, SonntagsZeitung reported earlier on Sunday. A Novartis spokesman quoted in the report said the seller was not in possession of materially relevant information. A company spokesman didn’t immediately respond to a request for comment from Bloomberg.

    The Swiss pharma company is under fire from U.S. lawmakers who say it should have told regulators about data irregularities before the drug’s approval in May, rather than waiting to conclude an internal investigation. The company told the FDA in June that it had discovered the potential manipulation of animal-testing data related to the medication, after the $2.1 million-a-dose treatment had already hit the U.S. market.

    Chief Executive Officer Vas Narasimhan said the company could have handled a furor surrounding Zolgensma better. Narasimhan, who became CEO of the pharmaceutical manufacturer last year, made the comment in a company call with 12,000 managers, according to newspaper Schweiz am Wochenende report yesterday.
     
  5. anonymous

    anonymous Guest

    Vas will some day resign and he will have made money to swim in. He will resign like the rest of the CEOs. What about the D to VP level mismanagement? They are just sitting around speculating when Vas will resign. These are the real crooks.
     
  6. anonymous

    anonymous Guest

    vas is sketchy. He and the avexis head should go. Lie to us once, shame on you. Lie twice,...
     
  7. anonymous

    anonymous Guest

    Vas did nothing wrong
     
  8. anonymous

    anonymous Guest

    Says who? Anyone who is here longer than four years has done something wrong. Otherwise it is impossible to survive in Pharma. If nothing else, then kiss ass, look the other way when they they can say or do something right, act like nothing happened, silent observer, join the community who is targeting a particular individual amongst other things.
     
  9. anonymous

    anonymous Guest

    best pipeline, worst ethics.
     
  10. anonymous

    anonymous Guest

    #VASknew
     
  11. anonymous

    anonymous Guest

    NOOOOOOOOOOO !!!

    Let him stay on and run the company into irrelevance; it'll be a good show, TRUST ME :)

    140% BPF.

    What is he thinking when we try to cut billions in costs.

    DAFUQ ?!?!
     
  12. anonymous

    anonymous Guest

    So HAS gets to interview for a promotion to keep doing nothing all day?